ArticleThe American journal of case reports2026
Delayed Thyroid Metastasis of Lung Adenocarcinoma Mimicking Primary Thyroid Carcinoma: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Thyroid metastasis from lung cancer is uncommon, accounting for approximately 8.3% of all thyroid metastases, which themselves occur in only about 1.4% to 3% of patients undergoing thyroid surgery; it poses significant diagnostic challenges due to its clinical and cytological resemblance to primary thyroid neoplasms. CASE REPORT We report the case of a 69-year-old woman with a history of non-small cell lung carcinoma (NSCLC) that had remained stable for 9 years, who presented with a progressively enlarging anterior neck mass. Ultrasound and fine-needle aspiration (FNA) initially suggested a benign thyroid lesion. However, given the marked interval growth of the nodule and the patient's oncologic history, a right thyroid lobectomy was performed for diagnostic and therapeutic purposes. Histopathology supported by immunohistochemical analysis was consistent with the diagnosis of metastatic adenocarcinoma of pulmonary origin involving the thyroid. Imaging studies did not demonstrate additional metastatic sites, although a small pulmonary nodule of uncertain importance was noted. She was subsequently referred for systemic therapy. We analyze the diagnostic challenges, histopathologic characteristics, limitations of FNA, and the critical role of immunohistochemistry in differentiating metastatic lesions from primary thyroid carcinoma. CONCLUSIONS This case highlights the potential for misdiagnosis of metastatic thyroid lesions, particularly when cytological findings suggest a benign nodule, and underscores the importance of integrating clinical history, imaging, and immunohistochemistry to achieve an accurate diagnosis. Long-term surveillance remains essential in cancer survivors, as metastatic disease can occur after a prolonged disease-free interval.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.